跳至主要内容
临床试验/JPRN-UMIN000031451
JPRN-UMIN000031451已完成4 期

Study for the effect on blood pressure and heart rate fluctuation by switching from DPP-4 inhibitor to SGLT2 inhibitor Luseogliflozin in patients with type 2 diabetes. - multicenter, prospective, randomized, open-label, parallel group, comparison study - - Luseogliflozin ABPM study

Hokkaido University Hospital0 个研究点目标入组 68 人开始时间: 2018年2月28日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with taking SGLT2 inhibitors. 2) Hypersensitivity to Luseogliflozin. 3) Uncontrolled diabetic retinopathy 4) Severe liver dysfunction, renal dysfunction, or heart failure 5) Pregnancy, nursing woman or possibly pregnant woman 6) Severe diabetic ketosis, diabetic coma 7) Severe infection, pre and post operation , severe trauma 8) Deficiency of insulin secretion 9) BMI < 22kg/m2 10) eGFR < 30 ml/min 11) Patients with uncontrolled diet therapy. 12) Patients with irregular circadian rhythm. 13) Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments

研究者

相似试验